Preparation method of chitosan oligosaccharide drug-loaded microcapsule
By using chitin oligosaccharide and metal ion chelation at the oil-water interface, the problems of low pesticide utilization and environmental pollution are solved, and the sustained release controlled release and plant growth regulation functions of pesticides are realized, improving the improvement of pesticides The stability of pesticides and the efficiency of pesticides are achieved.
Patent Information
- Application Number
- CN202411254537.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-12-06
AI Technical Summary
There are currently low pesticide utilization rate, high pest control costs, pesticide residues and environmental pollution problems, and no method of using chitin oligosaccharide chelated metal ions as capsule wall material to prepare microcapsules.
Chitosaccharides are used as carrier material, and through electrostatic attraction and metal ions chelation, chitosan capsule shell is formed at the oil-water interface, loading pesticide active ingredients and trace metal mineral elements to prepare excellent performance chitosaccharide drug-loading Microcapsules. The specific steps include adding chitosaccharides and aqueous metal ion solutions to the oil-water emulsion containing pesticide active ingredients to form stable microcapsules.
It improves the utilization rate and stability of pesticides, extends the effectiveness period, and reduces the number of pesticides used. In addition, the chitin oligosaccharide-loaded microcapsules have multiple functions of pest control, trace element supply and plant growth regulation, and are environmentally friendly.
Smart Images

Figure CN119073308A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of pesticides, in particular to a method for preparing chitosan oligosaccharide drug-loaded microcapsules. Background Art
[0002] Pesticides play a vital role in modern agriculture, effectively protecting crops from pests and diseases, thus ensuring food security and the sustainability of agricultural production. However, due to the characteristics of pesticides themselves (such as the easy photolysis of some active ingredients of pesticides), restrictions on application machinery, improper use methods, etc., the utilization rate of pesticides is low, which in turn leads to a series of problems such as increased costs for pest control, excessive pesticide residues and environmental pollution. Microencapsulation technology uses carrier materials to encapsulate or adsorb the active ingredients of pesticides, which can not only enable pesticides to obtain sustained-release and controlled-release capabilities, but also improve the stability of easily degradable pesticides, thereby increasing the utilization rate of pesticides.
[0003] Chitosan oligosaccharide is an oligosaccharide product with a polymerization degree between 2 and 20 after the degradation of chitosan. Chinese patent CN116445168A discloses a saline-alkali soil conditioner with slow-release and plant growth promotion functions and a preparation method thereof, including preparing a capsule shell using chitosan oligosaccharide and a cross-linking agent, and encapsulating a divalent cationic material in the capsule shell for saline-alkali soil conditioning. Chinese patent CN 102524300 A discloses a fungicide composition containing oligosaccharides and copper, which uses sodium alginate as a capsule wall material for preventing and controlling plant diseases.
[0004] At present, there is no report on the method of using chitosan oligosaccharide chelated metal ions as capsule wall material to load pesticide active ingredients to prepare microcapsules. Summary of the invention
[0005] In view of the above problems, the present application provides a method for preparing chitosan oligosaccharide drug-loaded microcapsules, which uses chitosan oligosaccharides as a carrier material and simultaneously loads pesticide active ingredients and metal trace mineral elements. First, electrostatic attraction is used to form a chitosan capsule shell on the oil-water interface of tiny oil droplets containing the pesticide active ingredients, and then the capsule shell is reinforced by the chelation effect of chitosan oligosaccharides and metal ions, thereby preparing chitosan oligosaccharide drug-loaded microcapsules with excellent performance.
[0006] Specifically, the technical solution of the present invention is as follows:
[0007] First, the present application discloses a method for preparing chitosan oligosaccharide drug-loaded microcapsules, that is, firstly, dispersing an oil phase containing pesticide active ingredients in an aqueous phase containing anionic surfactants to form an oil-in-water emulsion, then adding a chitosan oligosaccharide aqueous solution rich in positive ions to form a chitosan oligosaccharide capsule shell under the action of electrostatic attraction, and finally adding a metal ion aqueous solution to solidify the capsule shell under chelation to form a drug-loaded microcapsule; the specific steps are as follows:
[0008] S1. Prepare the pesticide technical as the oil phase for later use;
[0009] If the original pesticide is solid at room temperature, the original pesticide is fully dissolved in an organic solvent to form an oil phase; if the original pesticide is liquid at room temperature, it can be used directly as an oil phase or after adding an organic solvent and then used as an oil phase.
[0010] In the present application, the above-mentioned technical drugs are soluble in organic solvents, such as emamectin benzoate, cyhalothrin, prochloraz, pyraclostrobin, etc.; and almost all pesticides are soluble in organic solvents, so the present application method is applicable to a variety of pesticides. In specific implementation, the amount of organic solvent added is sufficient to completely dissolve the technical drug. For technical drugs with poor solubility such as emamectin benzoate, the amount of organic solvent added is generally 3-10 times the mass of the technical drug, while for easily soluble technical drugs such as prochloraz, the amount of organic solvent added is generally 0.3-1 times the mass of the technical drug.
[0011] S2. The anionic surfactant and the nonionic surfactant are fully dissolved in water to form an aqueous phase and set aside;
[0012] The anionic surfactant is selected from at least one of sodium dodecylbenzene sulfonate, calcium dodecylbenzene sulfonate, alkylnaphthalene sulfonate condensation product, and lignin sulfonate; the nonionic surfactant is selected from at least one of Tween 80, Nong Ru 600, Nong Ru 600P, castor oil polyoxyethylene ether, fatty alcohol polyoxyethylene ether, and EO-PO block copolymer.
[0013] Nonionic surfactants can be combined with anionic surfactants to improve the emulsification properties of the oil phase in the water phase, so that the oil droplets are dispersed in the water to achieve the required particle size (<5 microns).
[0014] S3. Under stirring conditions, the oil phase is slowly added to the water phase, and then sheared at high speed to form an oil-in-water emulsion;
[0015] S4. Under stirring conditions, the chitosan oligosaccharide aqueous solution is slowly added to the emulsion obtained in step S3 to form a chitosan oligosaccharide microcapsule suspension for standby use; the mass concentration of the chitosan oligosaccharide microcapsule suspension is preferably 1-20%;
[0016] S5. Under stirring conditions, slowly add the metal ion aqueous solution to the chitosan oligosaccharide microcapsule suspension obtained in step S4 to solidify the capsule shell to form chitosan oligosaccharide drug-loaded microcapsules; the molar concentration of the metal ion aqueous solution is preferably 0.05-1 mol / L. The particle size of the microcapsules prepared by the above method is less than 5 microns.
[0017] In the above preparation method, the stirring rate of "stirring" is preferably 200-1000 rpm, and more preferably 500-600 rpm; the rate of "high-speed shearing" is preferably 10000-30000 rpm, and more preferably 10000-20000 rpm.
[0018] Preferably, an auxiliary agent is added to the chitosan oligosaccharide drug-loaded microcapsules obtained in step S5, and a microcapsule suspension is formed after stirring (500-600rpm) evenly. The auxiliary agent includes conventional pesticide auxiliary agent components such as thickener, antifreeze agent, and preservative. For example, the thickener can be selected from at least one of xanthan gum, magnesium aluminum silicate, white carbon black and polyethylene glycol, the antifreeze agent is selected from at least one of ethylene glycol, propylene glycol, and glycerol, and the preservative is selected from at least one of methylisothiazolinone, methylchloroisothiazolinone and benzisothiazolinone.
[0019] In step S1 of the above preparation method, the organic solvent is preferably at least one of xylene, aromatic hydrocarbon solvent oil S100, S150, S200, methyl oleate, vegetable oil, N,N-dimethyldecylamide, N,N-dimethyloctanamide, cyclohexanone, isophorone, dibasic acid ester, ethylene glycol diacetate, N-octyl pyrrolidone, N-methyl pyrrolidone, dimethyl sulfoxide, N,N-dimethylformamide, ethanol, propanol, butanol, and acetonitrile; further preferably at least one of aromatic hydrocarbon solvent oil S100, S150, S200, methyl oleate, vegetable oil, cyclohexanone, N,N-dimethyldecylamide, cyclohexanone, N-octyl pyrrolidone, N-methyl pyrrolidone, N,N-dimethylformamide, and ethanol.
[0020] In step S2 of the above preparation method, the mass ratio of the anionic surfactant to the nonionic surfactant is preferably 1:0.1-1.
[0021] In step S5 of the above preparation method, the metal ion is selected from Zn 2+ , Cu 2+ , Fe 3+ , Fe 2+ , Ca 2+ Mg 2+ , Mn 2+ At least one of .
[0022] In the steps of the above preparation method, the mass ratio of added chitosan oligosaccharide to anionic surfactant is 1:0.5-5.
[0023] In the steps of the above preparation method, the mass ratio of the added chitosan oligosaccharide to the metal ions is 1:0.1-1; the metal ions chelate with the chitosan oligosaccharide to strengthen the capsule shell and do not affect the stability of the preparation.
[0024] In the steps of the above preparation method, the mass ratio of the total weight of the added anionic surfactant, chitosan oligosaccharide and metal ions to the oil phase is 1:1-10.
[0025] In the steps of the above preparation method, the mass ratio of the oil phase to the water phase is 1:1-10, preferably 1.07-2.92.
[0026] This application utilizes chitosan oligosaccharides to regulate plant growth and induce plants to acquire disease resistance. By inducing crops to produce defense responses, crops are improved in resistance to pathogens and abiotic stresses, while regulating plant growth, and improving crop yield and quality. Secondly, chitosan oligosaccharide molecules contain abundant amino functional groups. After dissolving in water, the amino groups are protonated and positively charged, and can form microcapsule shells by electrostatic attraction and negatively charged template reactions, thereby loading pesticide active ingredients. In addition, the amino and hydroxyl groups in the chitosan oligosaccharide molecules can react with metal element ions to form chitosan oligosaccharide metal chelates, thereby loading trace mineral elements.
[0027] The capsule shell of the present application is formed by the joint action of anionic surfactants, chitosan oligosaccharides and metal ions. The anionic surfactant provides a negative ion template, and the chitosan oligosaccharides and the negative ion template form a capsule through electrostatic attraction. The metal ions, chitosan oligosaccharides and anionic surfactants reinforce the capsule through chelation. Chitosan oligosaccharides are loaded with pesticide active ingredients and metal trace mineral elements at the same time, which can not only significantly improve the strength of the chitosan oligosaccharide capsule shell through the chelation of metal ions and chitosan oligosaccharides, but also enable the chitosan oligosaccharide drug-loaded microcapsules to have multiple functions such as pest control, trace element supply and plant growth regulation. The three main components of pesticides, chitosan oligosaccharides and trace mineral elements complement and promote each other, and jointly ensure the healthy growth of crops. Specifically, the beneficial effects of the present invention are:
[0028] 1. Chitosan oligosaccharides are used as the main body of the shell of drug-loaded microcapsules, which are non-toxic and environmentally friendly. The chitosan oligosaccharides produced by the disintegration of the capsule shell after application can be used as plant growth agents and inducers to promote plant growth and enhance stress resistance.
[0029] 2. Chitosan oligosaccharides are used as carriers to load pesticide active ingredients and metal trace mineral elements at the same time, so that the drug-loaded microcapsules have multiple functions such as pest and disease control, trace element supply and plant growth regulation. In addition, the three main components of pesticide active ingredients, chitosan oligosaccharides and trace mineral elements complement and promote each other to jointly ensure the healthy growth of crops.
[0030] 3. The present application uses metal ions as capsule shell materials, which react with chitosan oligosaccharide molecules to strengthen the capsule shell, significantly improving the stability of the microcapsules, making the chitosan oligosaccharide drug-loaded microcapsules have sustained-release and controlled-release capabilities, and can also effectively improve the stability of the pesticide active ingredients in the capsule core, thereby effectively extending the effective period and reducing the number of pesticide applications. In addition, after decomposition, metal ions can provide mineral nutrition for crops, or have bactericidal and disease-resistant effects (such as Cu 2+ 、Zn 2+ wait). BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 This is a microscopic image (400×) of the diluted solution of the chitosan oligosaccharide drug-loaded microcapsules prepared in Example 1.
[0032] Figure 2 This is a microscope image (400×) of a smear of the diluted solution of the chitosan oligosaccharide drug-loaded microcapsules prepared in Example 1.
[0033] Figure 3 This is a microscopic image (400×) of a smear of a dilution of the comparative preparation prepared in Example 1 without adding metal ions.
[0034] Figure 4 The following are photos of the preparations prepared in Examples 1-4. DETAILED DESCRIPTION
[0035] In order to more clearly and completely illustrate the technical solution of the present invention, it is now further described in conjunction with specific implementation methods. Obviously, the technical solution of the present invention includes but is not limited to the following implementation methods. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0036] Sources of medicines involved in the embodiments:
[0037] Emamectin benzoate technical (content 95%) was purchased from Hebei Weiyuan Biochemical Co., Ltd.;
[0038] Nongru 500 and Nongru 600 were purchased from Nanjing Taihua Chemical Co., Ltd.;
[0039] Chitosan oligosaccharide was purchased from Qingdao Honghai Biotechnology Co., Ltd.;
[0040] Methylisothiazolinone (MIT) and 0.1 g methylisothiazolinone (BIT) were purchased from Jinan Zhongbei Fine Chemical Co., Ltd.
[0041] High-efficiency cyhalothrin technical (content 95%) was purchased from Shandong United Pesticide Industry Co., Ltd.;
[0042] S150, solvent oil S100, and solvent oil S200 were purchased from Jiangsu Hualun Chemical Co., Ltd.;
[0043] EO-PO block polyether was purchased from Hai'an Petrochemical Plant, Jiangsu Province;
[0044] Alkylnaphthalene sulfonate polycondensate and sodium lignin sulfonate were purchased from Akzo Nobel;
[0045] Sodium dodecylbenzenesulfonate and Tween 80 were purchased from Shanghai MacLean Biochemical Technology Co., Ltd.;
[0046] Prochloraz technical drug (content 97%) was purchased from Nanjing Red Sun Co., Ltd.;
[0047] Pyraclostrobin technical (content 98%) was purchased from Shandong Hailier Chemical Co., Ltd.
[0048] The masses of reagents in the following examples are based on actual masses.
[0049] Example 1 Preparation of 2.3% aminoavermectin benzoate microcapsule suspension
[0050] The preparation steps are as follows:
[0051] 1) Heat 2.42 g of emamectin benzoate and 12 g of cyclohexanone to 60°C and stir until completely dissolved as the oil phase;
[0052] 2) dissolving 3 g of calcium lignin sulfonate, 0.5 g of calcium dodecylbenzene sulfonate (Nongru No. 500), and 0.6 g of Nongru No. 600 in 40 g of deionized water to form an aqueous phase;
[0053] 3) Under magnetic stirring at 500 rpm, the oil phase was slowly added to the water phase; and then high-speed shearing at 10,000 rpm for 2 minutes formed an oil-in-water milky white emulsion;
[0054] 4) under 500rpm stirring, slowly add 20g of chitosan oligosaccharide aqueous solution with a mass concentration of 10%, and then stir for 30 minutes; under stirring, slowly add 10g of zinc sulfate aqueous solution with a mass concentration of 10% (molar concentration of 0.619mol / L), and then stir for 30 minutes; then add 0.2g of xanthan gum, 3g of ethylene glycol, 0.1g of methylisothiazolinone (MIT), 0.1g of methylisothiazolinone (BIT), and make up to 100g with deionized water, and then stir evenly to prepare 2.3% avermectin benzoate microcapsule suspension, the substance of which is as follows Figure 4 As shown in A.
[0055] In the microcapsule suspension prepared in this example, the microcapsules are stable spheres with a diameter of about 2.5 microns (see the microscopic photograph). Figure 1 ), no original drug crystals precipitate after the dilution is dried (see Figure 2 ).
[0056] In this example, a comparative preparation without metal ions was prepared at the same time. Except that the zinc sulfate aqueous solution was not added, the other ingredients and preparation steps of the preparation were the same as above. The microscopic image of the smear of the comparative preparation dilution obtained was as follows: Figure 3 As shown, the comparative formulation is unstable, with a large amount of original drug crystals precipitated, which does not meet the requirements of pesticide formulations.
[0057] The product obtained in this example was tested using the "2% emamectin benzoate microcapsule suspension" disclosed in the corporate standard Q / LFD 010-200 of Liufuding Crop Protection Co., Ltd. The encapsulation efficiency of the preparation was >
[0058] 90%, suspension rate>95%, low temperature stability, freeze-thaw stability and hot storage stability are all qualified.
[0059] Example 2 Preparation of 5% highly effective cyhalothrin microcapsule suspension
[0060] The preparation method is as follows:
[0061] 1) 5.27 g of cyhalothrin technical drug and 10 g of solvent oil S150 were heated and stirred to completely dissolve as the oil phase;
[0062] 2) dissolving 3 g of alkylnaphthalene sulfonate polycondensate, 1 g of sodium dodecylbenzene sulfonate, and 0.6 g of EO-PO block polyether in 40 g of deionized water to form an aqueous phase;
[0063] 3) Under magnetic stirring at 600 rpm, the oil phase is slowly added to the water phase, and then subjected to high-speed shearing at 20000 rpm for 2 minutes to form an oil-in-water emulsion; under stirring, 20 g of a 15% chitosan oligosaccharide aqueous solution is slowly added, followed by stirring for 20 minutes; under stirring, 10 g of a 10% (molar concentration 0.617 mol / L) ferric chloride aqueous solution is slowly added, followed by stirring for 20 minutes; 0.15 g of xanthan gum, 4 g of glycerol, 0.1 g of methylisothiazolinone (MIT), and 0.1 g of methylisothiazolinone (BIT) are then added, and deionized water is added to 100 g, followed by stirring to prepare a 5% highly effective chlorfenapyr microcapsule suspension, the substance of which is as follows Figure 4 As shown in B.
[0064] The product obtained in this example was tested using the "10% highly effective cyhalothrin microcapsule suspension" disclosed in the enterprise standard Q / 320801GLD 087-2023 of Jiangsu Mingdelida Crop Science and Technology Co., Ltd. The D 90 <2.5μm, encapsulation rate>90%, suspension rate>95%, low temperature stability, freeze-thaw stability and hot storage stability are all qualified.
[0065] Example 3 Preparation of 25% Prochloraz Microcapsule Suspension
[0066] The preparation method is as follows:
[0067] 1) Heat and stir 25.8 g prochloraz technical drug and 10 g solvent oil S100 to completely dissolve as the oil phase;
[0068] 2) dissolving 4 g of sodium lignin sulfonate, 0.5 g of sodium dodecylbenzene sulfonate, and 1 g of Tween 80 in 35 g of deionized water to form an aqueous phase;
[0069] 3) Under 500rpm magnetic stirring, the oil phase is slowly added to the water phase, and then subjected to 15000rpm high-speed shearing for 3 minutes to form an oil-in-water emulsion; under stirring, 10g of 20% chitosan oligosaccharide aqueous solution is slowly added, and then stirred for 30 minutes; under stirring, 10g of copper sulfate solution with a mass concentration of 10% (molar concentration of 0.627mol / L) is slowly added, and then stirred for 30 minutes; 0.1g xanthan gum, 3g propylene glycol, 0.1g methylisothiazolinone (MIT), 0.1g methylisothiazolinone (BIT) are added, and deionized water is supplemented to 100g, and then stirred evenly to prepare a 25% prochloraz microcapsule suspension, which is as Figure 4 As shown in C.
[0070] In this embodiment, a comparative preparation without metal ions was prepared at the same time. Except that the copper sulfate aqueous solution was not added, the other ingredients and preparation steps of the preparation were the same as above. The obtained comparative preparation had poor stability and stratified after being left to stand for 3 days at room temperature, which did not meet the requirements of pesticide preparations.
[0071] The product obtained in this example was tested using the "30% prochloraz microcapsule suspension" disclosed in the enterprise standard Q / 320801GLD 029-2018 of Jiangsu Mingdelida Crop Science and Technology Co., Ltd. The D 90 <5μm, encapsulation rate>90%, suspension rate>95%, low temperature stability, freeze-thaw stability and hot storage stability are all qualified.
[0072] Example 4 Preparation of 9% pyraclostrobin microcapsule suspension
[0073] The preparation method is as follows:
[0074] 1) 9.19 g of pyraclostrobin technical drug, 15 g of solvent oil S200, and 3 g of cyclohexanone were heated and stirred to completely dissolve as the oil phase;
[0075] 2) dissolving 3 g of calcium lignin sulfonate, 2 g of alkylnaphthalene sulfonate polycondensate, and 1 g of Nongru 600P in 40 g of deionized water to form an aqueous phase;
[0076] 3) Under 600rpm magnetic stirring, the oil phase was slowly added to the water phase, and then subjected to high-speed shearing at 10000rpm for 3 minutes to form an oil-in-water emulsion; under stirring, 15g of a 15% chitosan oligosaccharide aqueous solution was slowly added, and then stirred for 30 minutes; under stirring, 15%
[0077] (molar concentration 0.929mol / L) 6g zinc sulfate solution, then stirred for 30 minutes; then added 0.1g xanthan gum, 4g propylene glycol, 0.1g methylisothiazolinone (MIT), 0.1g methylisothiazolinone (BIT), deionized water to 100g, then stirred evenly, to prepare 9% pyraclostrobin microcapsule suspension, the substance as Figure 4 As shown in D.
[0078] The product obtained in this example was tested using the "9% pyraclostrobin microcapsule suspension" disclosed in the enterprise standard Q / 3201AJ 079-2021 of Jiangsu Aijin Crop Science and Technology Group Co., Ltd. The D 90 <5μm, encapsulation rate>90%, suspension rate>95%, low temperature stability, freeze-thaw stability and hot storage stability are all qualified.
[0079] Example 5 Application of microcapsule suspension
[0080] The 2.3% emamectin benzoate microcapsule suspension and 2.3% emamectin benzoate microemulsion (Shenzhen Nopco Crop Science Co., Ltd.) in Example 1 were used for field efficacy test on controlling corn armyworm.
[0081] The experiment was carried out in Jiashu Village, Liulaozhuang Town, Huaiyin District, Huai'an City, Jiangsu Province on August 5, 2023. A total of three treatments were designed, including the 2.3% emamectin benzoate microcapsule suspension preparation of Example 1 at a dosage of 25 g / mu, the 2.3% emamectin benzoate microemulsion preparation at a dosage of 25 g / mu and a blank control, each treatment had 4 replicates, and each plot had an area of 30 m 2 Each plot was randomly arranged and sprayed evenly with a JACTO PJB-16 electric sprayer, with a water consumption of 30L / mu. The number of live insects on all corn plants in each plot was investigated before and on the 3rd, 7th, and 14th days after spraying, and the control effect was calculated according to the following formula.
[0082]
[0083] PT 0 —Number of live insects before application;
[0084] PT 1 —The number of live insects after application;
[0085] PT—Insect population reduction rate in the area treated with pesticides;
[0086] CK—insect population reduction rate in blank control area.
[0087] Table 1 Results of field efficacy tests on control of fall armyworm
[0088]
[0089] The test results show that the 2.3% emamectin benzoate microcapsule suspension prepared in Example 1 of the present invention, at a dosage of 25 g / mu, has a higher control effect on fall armyworm in corn fields than the control agent 2.3% emamectin benzoate microemulsion at the same dosage at 3 days, 7 days and 14 days after the application. It can be seen that the 2.3% emamectin benzoate microcapsule suspension in Example 1 of the present invention has excellent rapid effect and long-lasting effect.
[0090] Example 6 Application of microcapsule suspension
[0091] This example is a field test of the efficacy of 25% prochloraz microcapsule suspension and 25% prochloraz aqueous emulsion (Jiangsu Fengshan Biochemical Technology Co., Ltd.) prepared in Example 3 for controlling rice seedling disease
[0092] The experiment was carried out on June 5, 2023 at Heping Farm, Heping Town, Qingjiangpu District, Huai'an City, Jiangsu Province, using a direct seeding cultivation mode. A total of 3 treatments were designed, including 50g / 100kg of seeds at a dosage of 25% prochloraz microcapsule suspension formulation in Example 3, 50g / 100kg of seeds at a dosage of 25% prochloraz emulsion formulation, and a blank control. Seed treatment was carried out 2 days before sowing. According to the test dosage, the agent was diluted at a ratio of 1:50 between the slurry and the seeds, and then fully stirred with the seeds until the liquid was evenly distributed on the surface of the seeds. Dry it in the shade for later use. The sowing amount per mu is 10kg, with 4 replicates for each treatment, and the area of each plot is 30m 2 , and each plot was randomly arranged. The emergence rate was investigated 10 days after sowing, the incidence of rice seedling blight was investigated 30 days after sowing, and the incidence of rice seedling blight was investigated on September 6 at the rice heading stage. Samples were taken at 5 points in each plot, with 100 plants at each point. The control effect was calculated according to the following formula.
[0093]
[0094] Table 2 Results of field efficacy test on control of rice seedling disease
[0095]
[0096] This example was tested by one application and multiple investigations to find that the 25% prochloraz microcapsule suspension in Example 3 was safe for rice seed treatment at a seed dosage of 50g / 100kg and had no effect on the emergence rate. The 25% prochloraz microcapsule suspension at a seed dosage of 50g / 100kg had a higher control effect on rice seedling bakkan at both the seedling stage and the booting stage than the control agent 25% prochloraz emulsion in water. It can be seen that the 25% prochloraz microcapsule suspension in Example 3 of the present invention has an excellent control effect on rice seedling bakkan.
Claims
1. A method for preparing chitosan oligosaccharide drug-loaded microcapsules, characterized in that: The specific steps are as follows: 1) Use the pesticide technical as the oil phase for future use; If the original drug is solid, dissolve the original drug in an organic solvent as the oil phase; If the stock solution is liquid, it is used directly as the oil phase, or as the oil phase after adding an organic solvent; 2) Dissolve the anionic surfactant and the nonionic surfactant in water to form an aqueous phase for later use; The anionic surfactant includes at least one of sodium dodecylbenzene sulfonate, calcium dodecylbenzene sulfonate, alkylnaphthalene sulfonate polycondensate, and lignin sulfonate; the nonionic surfactant includes at least one of Tween 80, Nongru 600, Nongru 600P, castor oil polyoxyethylene ether, fatty alcohol polyoxyethylene ether, and EO-PO block copolymer; 3) Under stirring conditions, add the oil phase to the water phase and shear at a rate of 10000-30000 rpm to obtain an emulsion for later use; 4) adding the chitosan oligosaccharide aqueous solution to the emulsion under stirring to form a chitosan oligosaccharide microcapsule suspension for later use; 5) under stirring conditions, adding a metal ion aqueous solution to the chitosan oligosaccharide microcapsule suspension to obtain the chitosan oligosaccharide drug-loaded microcapsules; the metal ions include Zn 2+ , Cu 2+ , Fe 3+ , Fe 2+ , Ca 2+ Mg 2+ , Mn 2+ At least one of .
2. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: The organic solvent includes at least one of xylene, aromatic hydrocarbon solvent oil S100, S150, S200, methyl oleate, vegetable oil, N,N-dimethyldecylamide, N,N-dimethyloctanamide, cyclohexanone, isophorone, dibasic acid ester, ethylene glycol diacetate, N-octyl pyrrolidone, N-methyl pyrrolidone, dimethyl sulfoxide, N,N-dimethylformamide, ethanol, propanol, butanol, and acetonitrile; further preferably, it is at least one of aromatic hydrocarbon solvent oil S100, S150, S200, methyl oleate, vegetable oil, cyclohexanone, N,N-dimethyldecylamide, cyclohexanone, N-octyl pyrrolidone, N-methyl pyrrolidone, N,N-dimethylformamide, and ethanol.
3. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 2), the mass ratio of the anionic surfactant to the nonionic surfactant is 1:0.1-1.
4. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 3), the mass ratio of the oil phase to the water phase is 1:1-10.
5. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 4), the mass ratio of the added chitosan oligosaccharide to the anionic surfactant is 1:0.5-5.
6. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 4), the mass concentration of the chitosan oligosaccharide microcapsule suspension is 1-20%.
7. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 5), the concentration of the metal ion aqueous solution is 0.05-1 mol / L.
8. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: In step 5), the mass ratio of the chitosan oligosaccharide to the metal ion is 1:0.1-1; the mass ratio of the total weight of the anionic surfactant, chitosan oligosaccharide and the metal ion to the oil phase is 1:1-10.
9. The method for preparing chitosan oligosaccharide drug-loaded microcapsules according to claim 1, characterized in that: Adding auxiliary agents to the chitosan oligosaccharide drug-loaded microcapsules to prepare microcapsule suspensions; the auxiliary agents include at least one of thickeners, antifreeze agents and preservatives.
